Percutaneous administration of "Orthobiologics" offers the advantage of accelerated and functional recovery of musculoskeletal disorders. Stem cell optimizes the biological healing of diseases. The regenerative capacity of mesenchymal stem cells provides a pavement for clinicians to build up an organ of interest in vitro. Mesenchymal stem cells remain the perfect cell based tissue regeneration modality for treatment of musculoskeletal disorders in a minimally invasive environment without any significant morbidity. This article outlines the applications of mesenchymal stem cell administration in various musculoskeletal disorders.
The bases of orthobiologics are: • Matrix materials-Forms the ground substance and scaffold or frame work up-on which the stem cells forms the targeted tissue of interest.
• Growth factors-Potent substances to induce the tissue of interest.
• Stem cells-Biological cells which are cultured to produce the tissue of interest.
There are several forms of orthobiologics which are as follows: 1) Bone grafts.
2) Bone marrow aspirate. 
Stem cells
Stem cells are the naïve cells, blank cells (don't possess any cell surface markers) and uncommitted cells which can be differentiated into other cell types and can self renew to produce same type of stem cells exponentially in a controlled manner ( Figure 1 ). Broadly stem cells are classified into: a) Embryonic stem cells (ESC) [1] which are found in the inner mass of blastocyst, b) Adult stem cells (ASC) [1] which are found in bone marrow, adipose tissue or blood cells, c) Induced pluripotent stem cells (iPSC) [1] which are cultured in the laboratory to produce the tissue of interest.
Dynamics of stem cells [1]
Properties of stem cell [1] A) Self renewal b) Cell based delivery-Bone marrow is aspirated, and the stem cells are isolated, cultured and differentiated in laboratory media to increase their numbers before being applied to the injury site.
Embryonic stem cells (ESC)
Embryonic stem cells (ES cells or ESCs) are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early stage pre-implantation embryo.
Human embryos reach the blastocyst stage 4 -5 days post fertilization, at which time they consist of 50 -150 cells. Isolating the embryoblast, or inner cell mass (ICM) results in destruction of the blastocyst, a process which raises ethical issues. 
Properties of embryonic stem cells

Induced pluripotent stem cells
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. iPSCs are typically derived by introducing products of specific sets of pluripotency-associated genes, or "reprogramming factors", into a given cell type. iPSC derivation is typically a slow and inefficient process, taking 1 -2 weeks for mouse cells and 3 -4 weeks for human cells, with efficiencies around 0.01% -0.1%. Upon introduction of reprogramming factors, cells begin to form colonies that resemble pluripotent stem cells, which can be isolated based on their morphology, conditions that select for their growth, or through expression of surface markers or reporter genes. The challenges in iPSC are low efficiency, inadequate programming, genomic insertion and tumorigenic potential.
Method of induction of cells:
• Isolate and culture donor cells. 
Salient features of MSC [2] [3]
• Adherent fibroblast like morphology.
• No expression of hematopoietic stem cell markers such as CD34 and CD14.
• Expression of matrix markers such as CD44, CD29 and CD71.
• Expression of mesenchymal stem cell markers, SH2 and SH105.
• Contains extra cellular matrix components such as collagen, proteoglycans and fibronectin.
• Growth factors and cytokine receptors for TGF-β.
• Anti proliferative activity to inhibit T cell proliferation into tumorigenic cells. 
c) Tendons
The chronic and overuse of tendons leads to degenerative conditions such as plantar fasciitis, interscapular fibrofasciitis, tennis elbow, golfer's elbow and tendinopathies. Such degenerated tendon has an inferior potential to regenerate. Open Journal of Regenerative Medicine Autologous tenocyte injection is performed by a needle biopsy of healthy tendon which is subjected for isolation of cell of interest called tenocyte. Then tenocyte is amplified in cell cultured media and are injected into the injured or degenerated tendon [10] .
Tendon bioengineering using mesenchymal stem cells and a silk scaffold, allogenic adipose tissue derived mesenchymal stem cells and injection of micro-RNA with a loss of miR29 which results in increase in the production of type collagen 3 [11] .
d) Ligaments
Sports injuries will result in concomitant injury to ligaments which has very poor potential to regenerate. MSC along with bone morphogenetic protein 2 and In Duchene muscular dystrophy, the defect is due to mutation of dystrophin gene leads to the absence of dystrophin protein. MSC administration offers a greater advantage of contractile myotubules differentiation and regeneration of damaged myotubular system [17] .
In avascular necrosis of bone, the primary pathology is idiopathic. Some theories states avascular necrosis is due to increased intra-osseous pressure. The aim of surgery is to decompress the intra-osseous pressure by drilling multiple holes in the bone. Delivering of MSCs in the drill holes leads to osteointegration and osteogenesis which helps in remodelling of the bony structures [18] . 
Conclusion
MSCs admixed with micromolecules such as growth factors, cytokines & BMPs provide a three dimensional structure and biomechanically, structurally and functionally compliant to the naïve cells of host origin. Further research on the dosage and protocols on MSC for various disorders should be formulated which leads to decreased morbidity and improve the functional quality of life.
